Further evidence of association between mutations in FGFR2 and syndromic craniosynostosis with sacrococcygeal eversion

Birth Defects Res A Clin Mol Teratol. 2006 Aug;76(8):629-33. doi: 10.1002/bdra.20287.

Abstract

Background: Pfeiffer syndrome (PS; OMIM #101600) is an autosomal dominant disorder characterized by craniosynostosis, midface hypoplasia, broad thumbs, brachydactyly, broad great toes, and variable syndactyly.

Case: We report a case of PS (type 3) with tracheal and visceral involvement and sacrococcygeal eversion. The patient shows facial dysmorphism with macrocephaly, dolichocephaly, and trigonocephaly, and an asymmetric skull, bilateral and severe exophthalmia with shallow orbits and ocular hypertelorism, downslanting palpebral fissures, constant strabismus, short anterior cranial base, and midface hypoplasia.

Conclusions: Molecular analysis of the FGFR2 gene in this patient revealed a point mutation (c.890G>C NM_000141). This mutation leads to the substitution of the residue tryptophan at position 290 to cysteine in the protein (p.Try290Cys). These data reinforce the hypothesis that the p.Trp290Cys mutation is more often associated with a severe and poor prognosis of PS. Furthermore they suggest that the presence of sacrococcygeal defects is not associated with any specific FGFR2 mutation.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrocephalosyndactylia / classification
  • Acrocephalosyndactylia / genetics*
  • Acrocephalosyndactylia / pathology
  • Amino Acid Substitution
  • DNA Mutational Analysis
  • Female
  • Humans
  • Infant
  • Phenotype
  • Point Mutation
  • Prognosis
  • Receptor, Fibroblast Growth Factor, Type 2 / genetics*
  • Sacrococcygeal Region / abnormalities

Substances

  • FGFR2 protein, human
  • Receptor, Fibroblast Growth Factor, Type 2